© Copyright Nostre Net
Optical imaging refers to a technology that holds great
potential to improve the mode of treatment, disease diagnosis, and prevention
in the hospital operating room. This technology offers a host of benefits
compared to radiological imaging techniques. Optical imaging technique makes
use of non-ionizing radiation and reduces the patient’s radiation exposure,
which gives way to numerous studies over time. It also helps differentiate soft
tissues from native soft tissues or the tissues that posses exogenous or
endogenous contrast media using various photon absorption profiles at different
wavelengths. Optical imaging is a highly responsive imaging technique which can
be used by easily combining it with other imaging techniques.
Optical
Imaging Market Overview By Products, by Techniques, by Therapeutic Area, by
Application And End-Users Global Forecast Till 2030. The optical imaging market
is expected to be of value USD 3.44 billion in 2030 and to grow at a 9.7% CAGR
during the forecast 2022-2030.
Pharmaceutical and biomedical industries make heavy demand
for radiation-free imaging techniques, which accelerates the popularity of
optical imaging. Surging prevalence of neurological as well as ophthalmological
disorders among the worldwide population could accelerate demand for imaging
diagnosis, thereby elevating market growth. Technological advancement coupled
with increasing government support that benefits the healthcare industry paves
the way for several growth opportunities.
Some other growth-inducing factors driving market growth
include quick adoption rates of technically advanced devices, highly-developed
research infrastructure, and growing number of skilled professionals.
Technological advancement has led to complete transformation of medical
science, where optical imaging stands as the most affected aspect. This has
revolutionized the healthcare industry by increasing the ability to detect a
higher number of diseases.
Market Segmentation
The worldwide market for optical imaging has been segmented
on the basis of products, techniques, therapeutic area, application, and
end-user.
With respect to the type of product, the market comprises
imaging systems, software, lenses, illumination systems, cameras, and others.
Imaging systems can be sub-segmented into optical imaging systems and spectral
imaging systems.
Technique-wise, the market covers optical coherence
tomography (OCT), photoacoustic imaging, diffused optical tomography,
hyperspectral imaging, near-infrared spectroscopy, and super-resolution
microscopy.
Depending on the therapeutic area, the market covers
oncology, ophthalmology, neurology, cardiology, dermatology, dentistry, and
others.
Considering the application, the market caters to
pre-clinical and clinical research, pathological imaging, and intraoperative
imaging.
The end-users in the market include hospitals and clinics,
diagnostic imaging centers, pharmaceutical &biotechnology companies, and
research laboratories.
Regional Insight
Based on the geographical distribution, the optical
imaging market report has been studied in the primary regions of Europe,
the Americas, Middle East, and Africa and Asia Pacific.
The Americas has been identified as the largest market for
optical imaging. Rising prevalence of neurological, ophthalmic, and
cardiovascular disorders among the geriatric population triggers market growth
in the region. Moreover, a boost in the number of government initiatives along
with funding for research within the medical devices sector stimulates market
growth. Mounting demand for accurate diagnosis, high awareness regarding the
adverse effects of radiation imaging, and presence of highly regarded pharmaceutical
companies work in favor of the market. Also, vast patient pool in the region is
expected to augment market demand in the years to come.
Europe stands as the second leading market for optical
imaging. The robust share is the result of existence of advanced treatment
facilities, high healthcare expenditure, and well-developed healthcare
infrastructure. The flourishing medical device industry backed by the efforts
of prominent players adds to the market strength. Plus, rising knowledge with
regard to the benefits of optical imaging compared to radiation imaging spurs
the market growth in the region.
Asia Pacific could expand at the fastest rate, holding the
most promising growth prospects. A 2014 report by the department of neurology
reveals that among the present population of 1.27 billion, close to 30 million
people are afflicted with neurological disorders only in India. Therefore, the
huge patient pool combined with the fast rate at the healthcare technology is
catching up, the regional market is bound to note excellent gains in the near
future. The region also benefits from various government initiatives that help
improve healthcare quality and the availability of favorable insurance
policies. Apart from this, the lower cost of clinical trials and several
research companies striving to set up their regional headquarters as well as
manufacturing plants in China, Singapore, Korea, Australia, and Japan could
mark an optimistic market outlook in the subsequent years.
Middle East & Africa could showcase poor growth in the
global market. The factors holding back the market include limited access and
availability of treatment facilities and lack of awareness. In the Middle East,
Saudi Arabia and the United Arab Emirates (UAE) account for the substantial
share in response to the steadily expanding healthcare industry and increasing
number of specialty care centers. Overall, the regional market could
demonstrate consistent growth soon owing to rising number of government initiatives
aimed at enhancing the quality of healthcare.
Renowned Companies
Some of the renowned companies shaping the worldwide optical
imaging market are Bioptigen, Inc., Agfa-Gevaert N.V., Perkinelmer, Inc., Carl
Zeiss Meditec AG, St. Jude Medical, Inc., Topcon Corporation, Heidelberg
Engineering, Inc., Canon Inc., Koninklijke Philips N.V., among others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Surgical devices are types of instruments
that are used for performing numerous forms of surgeries in accordance to the
complexity of the surgery like minimally invasive, open, or other types of
surgery. The General Surgical Devices Market is anticipated to reach USD 15.1
Billion by 2030 at 8.60% CAGR during the forecast period 2022-2030.
General
Surgical Devices Market overview and analysis by Type (Disposable Surgical
Supplies, Open Surgery Instrument), Product (Handheld Devices, Laparoscopic
Devices), Application (Orthopedic, Cardiology), End-User (Hospitals, Clinics) -
Forecast Till 2030.As per the research conducted by Market Research
Future (MRFR), the market is identified to be influenced by numerous factors.
The high demand centered around disposable supplies like catheters, syringes,
and needles, the growing awareness concerning diseases being transmitted
through surgical forms of devices, and favorable government regulations in
ensuring or maintaining safety in surgical procedures are expected to stimulate
a positive demand for disposable products, thereby pushing the overall general
surgical devices market. An influx of global health initiatives causing
advancement in surgical procedures are expected to drive the global general
surgical devices market. However, factors like strict government regulations in
developing nations and improper reimbursement for surgical devices can cause
the market to falter in terms of growth.
Competitive Landscape
The global general surgical devices market
comprises of numerous players. A few of them identified in the report are 3M
Healthcare (U.S.), Johnson & Johnson Services, Inc. (U.S.), B. Braun
Melsungen AG (Germany), Grifols (Spain), SOFINA s.a (Biomérieux) (U.S.), Erbe
Elektromedizin GmbH (Germany), Integra LifeSciences (U.S.), Medtronic Plc.
(U.S.), Smith & Nephew (U.S.), Stryker Corporation (U.S.), Maquet Holding
B.V. & CO. KG. (Germany), CareFusion Corporation (U.S.), Becton, Dickinson
and Company (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Conmed Corporation
(U.S.), Accuray Incorporated (U.S), Boston Scientific Corporation (U.S.),
Ortho-Clinical Diagnostics, Inc. (U.S.), Intuitive Surgical Inc. (U.S.),
Siemens Healthcare GmbH (Germany), Cadence Inc. (U.S.), Thermo Fisher
Scientific, Inc. (U.S.), Virtual Incision Corporation (U.S.), Titan Medical
(Canada), Medrobotics Corporation (U.S.), TransEnterix Surgical (U.S.), Olympus
Corporations (U.S.), Verb Surgical (U.S.), Meere Company (U.S.), and others.
Market Segmentation
The global general surgical devices market
segmentation is done on the basis of application, type, product, and end-user.
By type, the market includes energy-based
and powered instrument, disposable surgical supplies, minimally invasive
surgery instruments, surgical instruments, medical robotics, open surgery
instrument, computer-assisted surgery devices, and others.
By product, the market includes
electrosurgical devices, trocars and access devices, handheld devices, wound
closure devices, laparoscopic devices, and others.
By application, the market comprises
thoracic surgery, ophthalmology, plastic surgery, orthopedic surgery,
cardiology, neurosurgery, audiology, into wound care, urology and gynecology
surgery, and others.
By end-user, the market includes research
centers, diagnostic centers, hospitals, academic institutes, clinics, and
others.
Regional Analysis
The global general
surgical devices market Research report is geographically segmented across
the following regions: Europe, America, Asia Pacific, and the Middle East and
Africa.
The Americas dominate the global market
with the highest share percentage and is expected to further maintain its
standings in the forthcoming years. This is due to the vast presence of key
players, a striking number of surgical procedures, favorable reimbursement
policies, and various initiatives undertaken by the government for providing
training sessions as well as access to advanced devices for physicians.
The Asia Pacific region is projected to
grow at the maximum pace during the forecast period owing to growing
investments alongside the regional expansion. The Middle East and Africa region
boasts the potential to emerge out as a big production hub for large-scale
development and medical devices. This is due to the low cost associated with
product development here in this region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Market Research Future (MRFR) has published
a research report about the global neurovascular
devices market trends to touch over USD 4.2 Billion by 2030. MRFR also
anticipates the global market’s growth to be at a rate of 5.7% during the
review period 2022 to 2030. This report talks about the market scenario and
future prospects regarding growth. In this report, the global neurovascular
devices market has been segmented on the basis of end-user, product,
therapeutic application, and lastly region.
Problems related to the nervous system are
serious. They cannot be seen easily, and their therapies usually lie in
surgeries where patients and doctors need to decide which surgeries are more
invasive and which are less invasive. Neurovascular devices are necessary for
treating neurovascular diseases. These devices have been developed due to
demand for minimally invasive procedures. There has never been a dearth of
neurovascular patients. Therefore, the global neurovascular devices market has
huge scope for growth. Factors contributing to the growth of this market
include favorable reimbursement policies, and ongoing product development &
commercialization.
On the basis of the end-users, this market
has been segmented into ambulatory surgical units and hospitals & clinics.
Ambulatory surgical units work for ambulatory surgery centers (ASC) that are
also known as outpatient surgery centers, same-day surgery centers, or
surgicenters. Ambulatory surgical units perform surgical procedures not
requiring an overnight hospital stay. Such surgery is commonly less complicated
than those required hospitalization.
Key Players
The key players in the global neurovascular
devices market include Abbott Laboratories (USA), Blockade Medical LLC.
(France), Delaware Corporation (USA), Evasc (Canada), Gynesonics (USA),
Johnson & Johnson Services, Inc. (the USA), Medikit Co., Ltd. (Japan),
Medtronic (USA), Merit Medical Systems Inc. (USA), MicroPort Scientific
Corporation (China), Neuravi (Israel), OxfordEndovascular (UK), Penumbra, Inc.
(USA), Rapid Medical (Israel), Sensome (France), Secant Group LLC (USA),
Stryker (USA), Terumo Corporation (Japan), and W. L. Gore & Associates,
Inc. (USA).
Segmentation:
The product-based segmentation segments the
market into aneurysm coiling & embolization devices, cerebral balloon
angioplasty & stenting systems, neurovascular
catheters, neuro thrombectomy devices, and a support device. The aneurysm
coiling & embolization devices segment has been sub-segmented into embolic
coils, flow diversion devices, and liquid embolic. Embolic coils block blood
flow into an aneurysm (weak area of an artery). The embolic protection systems
have been segmented into balloon occlusion devices and distal filter devices.
Cerebral angioplasty is a procedure useful for opening the partially blocked
carotid and vertebral arteries in the neck. They can also do the same for blood
vessels within the brain. It has been segmented into is sub-segmented into
carotid artery stents and embolic protection systems. Stenting system indicates
an improvement of coronary luminal diameter in patients with symptomatic
ischemic heart disease. Neurothrombectomy devices are used for treating acute
ischemic strokes. They have been sub-segmented into aspiration devices,
retrieval systems, and suction devices. Based on therapeutic application, the
market has been segmented into the hemorrhagic stroke and ischemic strokes. A
hemorrhagic stroke can be defined as either a brain aneurysm burst or a
weakened blood vessel leak. The different types of ischemic strokes occur when
the body is deprived of oxygen or any other important nutrients.
The regional segmentation of the global neurovascular
devices market Report comprises of The Americas (North America & South
America), Europe, Asia Pacific, and Middle East & Africa (MEA) region. The
Americas dominate the global neurovascular devices market due to a large number
of patients suffering from neurovascular diseases like arteriovenous
malformations (AVMs) and brain aneurysm. Due to technological advancement, high
disposable income, and the availability of better medical facilities, North
America is the bigger market than South America. Moreover, increasing healthcare
expenditure, government aid to researches in the field of medical sciences and
the presence of the key players in North America boosts the growth of the
market in North America. Majority key players in this region are based in the
United States of America (USA).
The Asia Pacific region is the fastest
growing market for the market due to continuously developing economies like
China and India, increasing demands for minimally invasive surgeries by the
growing geriatric population, and the presence of a huge patient population.
Asia Pacific region is yet to achieve the infrastructure development and
technological advancement as par the level of North America and Europe, and
there are few countries in this region that are technologically advanced. In
the Asia Pacific region, the biggest markets are Australia, China, India,
Japan, and South Korea, followed by the rest of Asia Pacific. MEA region is a
small market due to political instability in most countries due to movements
like Arab Spring. Lack of technology and less investment in healthcare due to
healthcare not being considered a priority by governments in this region are
the reasons for a small market. The biggest markets in this region are Kuwait,
Oman, Saudi Arabia, Qatar, and United Arab Emirates (UAE), followed by rest of
MEA region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Surgical
Robots Market Overview and analysis By Product Type, By Application, By
Control Mechanism, By End-User and Region—Forecast till 2030
The Global Surgical Robots Market is growing with the rapid
pace mainly due to the burgeoning Healthcare Industry. According to a
recent study report published by the Market Research Future, The surgical
robots market size was valued at USD 4.21 billion in 2021 and is projected to
grow from USD 5.05 Billion in 2022 to USD 21.41 billion by 2030, exhibiting a
compound annual growth rate (CAGR) of 5.8% during the forecast period (2022 -
2030).
Advancements in technology have empowered surgeons to
remotely operate robots and perform surgery. Surgeons can perform a surgical
procedure in emergency situations through telesurgery, with the aid of an
imaging device. There are many advantages of robotic surgery over
traditional open surgery like more accuracy, less pain, small insertions and
many more. Increasing automation in healthcare sector and increasing
demand for the minimally-invasive surgeries and more advances robotics has
led to growth of this market across the globe. Beside this increasing incident
of cancer, different neurological disorders and many more diseases has provided
fuel for the growth of the market. Additionally, advancements in technology
over the fast few years have been directed towards reducing costs of products.
This has led to increasing applications of these robots for various tasks.
While high cost of surgical robots, risks associated with
the robotic surgeries and the scepticism toward technology may hamper the
growth of the market. Adversely, the development of Surgical robots with high
artificial intelligence technology is driving the Surgical robots market.
Surgical Robots Global Market – Segments
The Surgical Robots Market can be segmented in to 4 key
dynamics for the convenience of the report and enhanced understanding;
Segmentation By Control Mechanism : Comprises Direct
Telemanipulator and Computer Control.
Segmentation By Robotic Surgery Approach : Comprises Supervisor-Controlled
Robotic Surgical System, Shared Control Robotic Surgical Systems, Telesurgery
Systems, Robotic Radiosurgery Systems.
Segmentation By Application : Comprises General Surgery, Cardiac
Surgery, Gynecologic Surgery, Colorectal Surgery, Urologic Surgery, Head
and Neck Surgery and other.
Segmentation By Regions : Comprises
Geographical regions - North America, Europe, APAC and Rest of the World.
Surgical Robots Global Market – Competitive
Analysis
Characterized by the presence of well-established players; Surgical
Robots market research report appears to be highly competitive. Well
established players incorporate acquisition, collaboration, partnership,
expansion, and product launch in order to gain competitive advantage in this
market and to maintain their market position. Vendors are focusing on improving
their market performance and are expanding by acquiring promising companies in
the fast-growing markets. Marketers employ a continuous improvement strategy
to analyze and update the software, implementing improvements
and launching new technologies to meet the changing needs of consumer.
These manufactures develop a well-established infrastructure that allows
seamless implementation of advanced technologies. They strive to develop
unravel design and adept technology Heavy investments are transpired in R&D
sector from the major players which is in turn helping the market to
grow.
In view of growth and immense revenue generation
opportunities potential that market is currently demonstrating is in turn
attracting several new players to enter the market. However, those new entrants
find it challenging to survive in the market with the introduction of new
technologies.
Surgical Robots Global Market – Regional Analysis
On regional basis, America has the largest market for
surgical robots. Availability of finance, well developed healthcare sector with
continuous increasing prevalence of number of diseases are the major driving
factor for America surgical robots market. North America is the major
contributor for the Americas surgical robots market. In 2016, North America
surgical robots market was USD 1,655.8 million. Europe has second leading
market which is followed by Asia Pacific region. Increasing prevalence of diseases
like cancer and many neurological disorder in Europe has help to grow this
market. Asia Pacific region is showing slow growth for surgical robot market.
Asia Pacific surgical robots market is expected to grow at a CAGR of 23.36 %
forecast period from 2017-2023
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Healthcare
Protective Masks Market Trends was estimated to be USD 2,050.2 Million in
2019 and Healthcare Protective Masks Market is expected to reach USD 9.88
Billion by 2030. It is predicted to grow at a CAGR of 5.7% from 2022 to 2030. Furthermore,
the rising prevalence of age-related diseases, mass manufacturing operations in
Southeast Asian countries, increasing investments in healthcare facilities, and
increasing levels of pollution, are also expected to boost the market during
the forecast period.
However, manufacturers providing
low-quality face masks, and a rise in prices of face masks are expected to
restrain the growth of the healthcare protective masks market.
Several market players such as 3M, Cardinal
Health Inc., and Medline Industries Inc. among others currently dominating the
global healthcare protective masks market.
Key Players
Some of the key players in the global
healthcare protective masks market are 3M (US), Cardinal Health, Inc. (US),
Narang Medical Limited (India), Mölnlycke Health Care AB (Sweden), Henry
Schein, Inc. (US), Medline Industries, Inc. (US), Sterimed (India), Honeywell
International Inc. (US), Kimberly-Clark Corporation (US), Ansell Ltd
(Australia), Dynarex Corp. (US)
Segmentation
Global Healthcare Protective Masks Market
has been segmented based on the Product Type and The End User.
Based on the product type, the global
healthcare protective masks have been segmented into surgical masks, anesthesia
masks, and respirators. The surgical masks segment is expected to be the
largest market segment.
On the basis of end user, the market is
segmented into hospitals & clinics, and ambulatory surgical centers. The
ambulatory surgical center segment is expected to be the fastest-growing
segment.
Regional Analysis
The Healthcare
Protective Masksmarket report has been divided, by region, into the
Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas
region held the largest market, owing to the rise in COVID-19 cases in the
region. The healthcare protective masks market in the Americas has further been
branched into North America and Latin America, with the North American market
divided into the US and Canada. The European healthcare protective masks market
has been categorized as Western Europe and Eastern Europe. The Western European
market has further been classified as Germany, France, the UK, Italy, Spain,
and the rest of Western Europe. The healthcare protective masks market in
Asia-Pacific has been segmented into China, India, Japan, Australia, South
Korea, and the rest of Asia-Pacific. Due to the increasing number of surgical
procedures, the market in Asia-Pacific is expected to be the fastest-growing.
The healthcare protective masks market in the Middle East & Africa has been
divided into the Middle East and Africa.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Cellulite
production has swelled in recent years due to poor nourishment, static
postures, dehydration, inflammation, eating habits, alcohol intake, among other
factors. The global cellulite treatment market Share is expected to reach USD 1.33 Billion by
2030 and register a CAGR of10.90% during the forecast period of 2022 to
2030.
Most
corporate employees with cellulite are working on their wellbeing and fitness
to amplify their productivity. Resultantly, many firms are partnering with
clinics and hospitals to help their staff stay healthy.The cellulite treatment market is
motivated by the tremendous influx of female population in metro centers due to
employment as younger employees are more health-conscious and press for a
better physique to avoid medical problems.
The foremost players in the cellulite
treatment market areNubway (China), Zimmer
Aesthetics (Germany), Skinrex Co., Ltd. (South Korea), Cymedics (Germany),
Tanceuticals, LLC. (US), Cynosure, Inc. (US), Inceler Medikal Co. Ltd.
(Turkey), Syneron Medical Inc (US), Hologic Inc. (US), Cutera (US), Beijing
Sincoheren S & T Development Co., Ltd, (China), Candela Medical (US), and
Merz Pharma GmbH & Co. KGaA (Germany).
Detailed
Regional Analysis
The
regional assessment of the cellulite treatment market includesNorth America,
Asia-Pacific, Europe, and other important regions. North America will have the
greatest cellulite treatment market share in 2020, owing to well-established
product development research groups, the availability of novel treatment
products, the consumption of unhealthy diets, and the significant desire for
the sculpted figure. The primary players are expanding their operational
facilities across the region, collaborating in collaborations and partnerships,
and launching new products to drive economic interests. Due to the
transformation of healthcare infrastructure, the construction of R&D
facilities, and increased awareness about body contouring and physical
wellness, the Asia-Pacific cellulite treatment market is estimated to be the
fastest regional market.
Segmental
Analysis
The
segmentation of the cellulite treatment market outlook has been conducted based on cellulite type,
treatment procedure, region, and end use. The cellulite treatment market is
divided into three segments based on end use: specialized dermatological
clinics, hospitals, and ambulatory surgical centers. The cellulite treatment market has been
segmented based on treatment procedures into minimally invasive, non-invasive, and topical treatment. The
cellulite treatment market has been divided into three segments based on
cellulite type: soft cellulite, hard cellulite, san francisco cellulite
treatment and edematous cellulite. The region segment of the cellulite
treatment market includes North
America, Asia-Pacific, Europe, and other important regions.
Competitive
Analysis
The continuation of occasional lockdowns in
numerous regions may cause the market expansion to be hampered if resources
such as labor and supply chains are severely impacted. The global market is
expected to diversify in operational techniques as innovative models for
operation and delivery are implemented. Government assistance is expected to
support worldwide market development in the next years. Due to the return of
COVID cases in many locations, the market may exhibit constrained growth. It is
projected that the emphasis on accumulating reserves of resources to deal with
unexpected crises would impact future market trends. Market developments and
research are expected to generate attractive growth opportunities in the next
years. The reliance on online commerce for sales is expected to increase
significantly during the forecast period, prompting market stakeholders to
invest more in its growth.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The pain patch market is expected
to reach USD 21324 Million by 2030 at 4.80% CAGR during the forecast period
2022-2030. Pain-relief patches also known as pain patches can be easily
purchased from pharmacies. They are available in different types, however, most
of the pain patches are used for managing both short-term and long-term pain.
This clearly means that a pain patch can be prescribed for both acute and
chronic pain conditions. This flexibility and effectiveness helps the companies
in the global market for pain patch grow as the demand for these products
remains strong throughout the year, and its easy availability has given more
boost to the market.
A pain
patch market when placed on the skin helps the skin absorb a certain amount
of medication which helps prevent or reduce pain. The medication easily gets
absorbed into the bloodstream, however the type of medication and patch
prescribed by physicians may vary depending on the actual need of the patients
and levels of the pain. Prescription based pain patches may include diclofenac
epolamine, an anti-inflammatory nonsteroidal drug, a local anesthetic known as
lidocaine, and opioid pain medication.
For minor injuries, physicians recommend a
pain patch with diclofenac epolamine. This formula helps in reducing and
controlling minor pain caused due to muscle strains and sprains. This element
falls under the same group as ibuprofen and aspirin. Patients are asked to be
careful and not use such patches anywhere on a broken skin. A study published
by expert analysts has found that such pain patches can provide pain relief for
soft-tissue injuries with few adverse effects.
Pain Patch Market Key Players
The global Pain
Patch Market playersis marked by the presence of eminent players
such as
Pain Patch Market Segmentation
For the scope of research, analysts have
segmented the pain patch market based on type, mode of administration, end
users, and therapeutic use.
Pain Patch Market Regional Overview
Industry experts have analyzed the global
pain patches market at different levels. The report brings information from
across the world and provides key insights into regional pain patch markets
from the Americas, which is the largest market in the world for pain patches.
The growth here is due to an increasing number of patients with chronic
diseases and spinal injury. The report also covers the European market where
demand for pain patches is on the rise. Other regional pain patch markets
covered in the report are Asia-Pacific and the Middle East and Africa. For each
of these regions, analysts have also presented country-level trends,
predictions, and market status details along with profiling of key players
present in the global pain patch market.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The Mobile Tablets in
Healthcare Market sizeis projected
to reach USD 128.67 Million by 2030 at 4.10% CAGR during the forecast period
2022-2030. Ease of access to
information and operation and constant development in such devices to ensure
the better user experience is going to ensure a better growth rate for the
market. This market is also going to witness better growth as the increase in
its adoption by healthcare professionals can impact the market more. Patients
are also ensuring better uptake. Surging participation from the pharmaceutical
industries in terms of app developments to make sure it gets better
acknowledgment from doctors, patients, and nurses. Prompt availability of
various information is also going to ensure better uptake of mobile tablets in
healthcare. The biotech industry is also on a course to ensure better growth
for mobile tablets in the healthcare market.
But the mobile tablets in
the healthcare market may find the cost of these devices to be a restraint.
Complicated technicalities can also deter people from adopting such
technologies, which can hold back the market growth.
Regional
Analysis:
The Americas, as per the
report is the largest regional market that is witnessing a remarkable hike in
the adoption of mobile tablets in healthcare due to better investment
facilities, strong per capita income, and heightened inclusion of the
technologies to facilitate such provisions. Infrastructural superiority of the
region, especially in countries like the US and Canada can make sure that the
region receives better support. In Europe, this growth can be viewed mostly in
countries like the UK, France, Germany, Italy, and other western European
countries. Lack of financial support in the Eastern segment may hold back the
market growth. However, the inclusion of IT in healthcare is providing scope
for market growth.
In the Asia Pacific
region, the growth would be the fastest as emerging economies are going to
increase their healthcare-related expenditure and allow the IT sector to
permeate easily. Various major hospitals and clinics are going to inspire
better growth for the market. The Middle East & Africa may find their
infrastructural lack to be the major market deterrent. This is due to the poor
economic condition of many countries.
Segmentation
The global report
covering the mobile tablets in healthcare market insightshas been segmented by application and end
users by MRFR for a detailed discussion. This analysis provides insights and
inputs that can assist companies in devising better strategies to increase the
profit margin.
By application, the
global report on the market for mobile tablets in the healthcare covers patient
monitoring & data collection, prescribing & issuing medicine, dashboard
& reports, appointment scheduling. The patient monitoring & data
collection segment is the largest one as the growing use of observational
studies and the collection of data from it is becoming the norm of various
treatment procedures.
By end user, the report
on the global market for mobile tablets in the healthcare can be segmented into
hospitals & clinics, government organizations & research centers, and
others. In the hospitals & clinics segment, the market finds substantial
growth opportunities as these tablets help in the optimal usage of all the resources.
In research centers, constant monitoring of patients is expected to provide
growth for the market. The ‘others’ segment includes ambulatory surgical
centers and pharmacists’ laboratories.
Competitive
Analysis
The market for the mobile tablets in the healthcare
has players like Apple Inc (US), Hewlett-Packard (US), Barco (Belgium), Samsung
Group (South Korea), Microsoft Corporation (US), Zebra Technologies Corp (US), Sand
Dune Ventures, Inc (US), Advantech Co., Ltd (Taiwan), ASUSTeK Computer Inc
(Taiwan), Teguar Computers (US), Dell (US), ARBOR Technology Corp (Taiwan), and
HCL Technologies (India).
Samsung, in their recent endeavors, made a pact with
Aetonix to improve their aTouchAway Enterprise platform and establish greater
connectivity for patients, caregivers, nurses, and doctors using mobile remote
patient monitoring solutions as a mode.
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
The Medical
Tourniquets Market is expected to reach USD 687.21 Million by 2030 at 12.4%
CAGR during the forecast period 2022-2030. Medical tourniquets play an
essential role in complex medical procedures and emergencies to regulate blood
flow. These devices are used to prevent blood loss by compressing blood vessels
and assist medical professionals in carrying out medical procedures with
minimum blood loss. Tactical tourniquet, pediatric tourniquet, military
tourniquet, surgical tourniquet, emergency medical tourniquet, emergency medical
tourniquet are commonly used tourniquets to control arterial blood flow.
The growth of global medical tourniquets market is
determined by numerous factors such as an increasing global geriatric
population which is directly responsible for rising surgical procedures, high
prevalence of road accidents, and growing number of joint replacement
surgeries. However, the shortage of medical professionals in developing regions
is likely to hamper the growth of the global medical tourniquets market during
the forecast period.
Several market players currently dominate the global medical
tourniquets market. The key players are involved in product launches and
strategic collaborations to strengthen their market positions.
Key Players
Some of the key players in the global medical tourniquets
market are Zimmer Biomet, StrykerCorporation, Delfi Medical
Innovation, OHK Medical Devices, Huaxin Medical Equipment Factory, Sam Medical,
Hammarplast Medical AB, VBM Medizintechnik, Ulrich Medical, Pyng Medical
(Part of Teleflex), C.A.T Resources, Rudolf Riester GmbH, Anetic Aid,
Dessillons & Dutrillaux, and Hangzhou Zhengda Medical Co.
Segmentation
The global medical
tourniquets market insights has been segmented based on type, application,
and end user.
The market, based on type, has been divided into tourniquet
systems, tourniquet cuffs, and tourniquet accessories. The tourniquet cuffs
segment has been further classified as pneumatic and non-pneumatic cuffs.
Tourniquet systems are likely to hold the maximum market share in the global
medical tourniquets market.
The global medical tourniquets market on the basis of
application has been segregated into lower limb medical tourniquets. The lower
limb medical tourniquets segment is expected to hold a larger share of the
market share owing to the rising joint replacement surgeries.
The end user segment of the market consists of hospitals and
trauma centers, ambulatory surgery centers, specialty clinics, and others. The
hospitals and trauma centers segment is expected to hold the largest share of
the market as these centers are the primary locations for patients receiving
treatment and undergoing surgery.
Regional Analysis
The market has been divided, by region, into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is anticipated to hold the largest market share
owing to the increasing number of surgeries, well-established healthcare
sector, and increasing incidences of gun violence. The medical tourniquets
market in the Americas has further been branched into North America and Latin
America, with the North American market being divided into the US and Canada.
The European medical tourniquets market has been categorized
as Western Europe and Eastern Europe. The Western European market has further
been classified as Germany, France, the UK, Italy, Spain, and the rest of
Western Europe. The medical tourniquets market in Asia-Pacific has been
segmented into Japan, China, India, South Korea, Australia, and the rest of
Asia-Pacific. Due to the presence of a large patient pool, rising geriatric
population, the market in Asia-Pacific, is expected to be the fastest-growing.
The medical tourniquets market in the Middle East & Africa has been divided
into the Middle East and Africa.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Diabetic
Ulcer Treatment Market size is expected to reach USD 7.5 billion by 2030 at
CAGR of 8.5% during the forecast period 2022-2030. The large healthcare
expenditure of nations in Europe, Americas, and other developing countries can
drive the diabetic ulcer treatment market growth exponentially. Rising number
of diabetics has driven the need for diabetic ulcer treatment. According to the
American College of Physicians, diabetic foot ulcers statistics accounted to
6.3% cases annually. Standards outlined by healthcare organizations for getting
annual foot exams annually can work in favor of the diabetic ulcer treatment
market.
Diabetic ulcers are open wounds that appear
in diabetics at the bottom of their foot. It is most commonly found in older
men. Treatment of ulcers and amputations caused by these cost massive
hospitalization fees and has triggered the need for effective therapies and
methods. The global diabetic ulcer treatment market report by Market Research
Future (MRFR) looks at amputations and neurological indications of these ulcers
and predicts the future of their treatments for the period of 2022-2030.
Technological developments in wound care
products and its subsequent adoption in healthcare organizations can fuel the
diabetic ulcer treatment market growth. Removal of dead tissues, control of
blood sugar levels, and hyperbaric surgery are few treatment options for
diabetic ulcers.
Diabetic
Ulcer Treatment Market Competitive Outlook
Cardinal Health, Integra LifeSciences
Corporation, ACELITY L.P. INC., Essity Aktiebolag, Smith & Nephew PLC,
Organogenesis Inc., Mölnlycke Health Care AB, Braun Melsungen AG, SANUWAVE
Health, Inc., ConvaTec Group PLC, and 3M are some of the notable players
profiled in the global diabetic ulcer treatment market. Mergers, new product
launches, and acquisitions are prime strategies of the players in the market.
Recently, Organogenesis Holdings Pvt Ltd. has launched biomaterials in an
effort to expand its wound dressing product line and to appeal to patient
demand. Clinical trials are also being conducted to test the efficacy and
performance of treatments.
Diabetic
Ulcer Treatment Market Segmentation
The Global Diabetic ulcer treatment market
insights has been segmented by type, treatment, and end-user.
By type, Diabetic Ulcer Treatment Market
has been divided into foot ulcer and mouth ulcer. The foot ulcer segment
accounted for a large share of the global market. The primary factor driving
the segment growth is the complications arising due to diabetes mellitus and
the large pool of patients. Use of wound dressings and biologics for lowering
the rate of amputations and successful treatment of DFU can drive the diabetic
foot ulcer market during the forecast period.
By treatment, the diabetic ulcer treatment
market is segmented into active therapies, wound care dressings, diabetic foot
ulcer treatment products and wound care devices. Wound dressing held the
largest share of the market due to the large number of diabetics.
By end-user, the diabetic ulcer treatment
market is segmented into academic and research organizations, hospitals and
clinics, and ambulatory surgical centers. Hospitals and clinics accounted for
the largest market share due to awareness campaigns by governments and
favorable reimbursement schemes. Launch of mobile applications for creating
awareness among the masses has successfully driven patients towards hospitals
and clinics for diabetic ulcer treatment.
Diabetic
Ulcer Treatment Market Regional Analysis
Europe, Asia Pacific (APAC), the Middle
East & Africa (MEA), and Americas are regions covered with respect to the
global diabetic ulcer treatment market.
The Americas can spur the demand for
diabetic ulcer treatment due to the large number of cases of diabetics.
According to the American Podiatric Medical Association, close to 14-24% of
Americans with diabetic foot ulcers have undergone amputations. The high
potential of the combination of debridement and continuous diffusion of oxygen
(CDO) has seen successful outcomes in treatment of diabetic foot ulcers (DFU).
APAC can display a robust growth rate
during the forecast period owing to a large patient pool and the developing
healthcare sector in India and China.
Market Dynamics
The mobility or musculoskeletal systems,
such as muscles, tendons, and ligaments, are affected by diabetic ulcer
treatment. Repetitive motion injuries are another name for these conditions.
Treatment for diabetic ulcers can be as simple as repeating the same motion or
lifting heavy objects. They affect many regions of the body, primarily the
upper and lower backs, as well as the neck.
Various factors such as the growing
worldwide geriatric patient population, rising prevalence, and rising
prevalence rate of diabetic foot ulcer patients are driving the growth of the
global diabetic ulcer treatment market. In many developing nations, lack of
information of diabetic ulcer treatment choices and a scarcity of qualified
experts in diabetic ulcers, particularly foot ulcer care, are likely to stifle
market expansion.
Several major companies currently control
the worldwide diabetic ulcer therapy market. To increase their market
positions, the leading companies are involved in product launches and strategic
collaborations. Many prominent players' geographic expansion product offerings
are also likely to give a fantastic chance for the market to grow
significantly.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.